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RESEARCH ARTICLE Open Access
Differential rates of intravascular uptake
and pain perception during lumbosacral
epidural injection among adults using a 22-
gauge needle versus 25-gauge needle: a
randomized clinical trial
Robin Raju1* , Michael Mehnert2, David Stolzenberg2, Jeremy Simon2, Theodore Conliffe2 and Jeffrey Gehret2
Abstract
Background: Inadvertent intravascular injection has been suggested as the most probable mechanism behind serious
neurological complications during transforaminal epidural steroid injections. Authors believe a smaller gauge needle may
lead to less intravascular uptake and less pain. Theoretically, there is less chance for a smaller gauge needle to encounter
a blood vessel during an injection compared to a larger gauge needle. Studies have also shown smaller gauge needle to
cause less pain. The aim of the study was to quantify the difference between a 22-gauge needle and 25-gauge needle
during lumbosacral transforaminal epidural steroid injection in regards to intravascular uptake and pain perception.
Methods: This was a prospective single blind randomized clinical trial performed at outpatient spine practice locations of
two academic institutions. One hundred sixty-two consecutive patients undergoing lumbosacral transforaminal epidural
injections from February 2018 to June 2019 were recruited and randomized to each arm of the study – 84 patients were
randomized to the 22-gauge needle arm and 78 patients to 25-gauge arm. Each transforaminal injection level was
considered a separate incidence, hence total number of incidence was 249 (136 in 22-gauge arm and 113 in 25-gauge
arm). The primary outcome measure was intravascular uptake during live fluoroscopy and/or blood aspiration. The
secondary outcome measure was patient reported pain during the procedure on the numerical rating scale.
Results: Fisher exact test was used to detect differences between 2 groups in regards to intravascular uptake and paired
t-tests were used to detect differences in pain scores. The incidence of intravascular uptake for a 22-gauge needle was
5.9% (95% confidence interval: 1.9 to 9.8%) and for a 25-gauge needle, 7.1% (95% confidence interval: 2.4 to 11.8%) [p =
0.701]. Average numerical rating scale scores during the initial needle entry for 22-gauge and 25-gauge needle was 3.46
(95% confidence interval: 2.94 to 3.98) and 3.13 (95% confidence interval: 2.57 to 3.69) respectively [p = 0.375].
Conclusions: The study showed no statistically significant difference in intravascular uptake or pain perception between a
22-gauge needle and 25-gauge needle during lumbosacral transforaminal epidural steroid injections.
Trial registration: ClinicalTrials.gov NCT04350307. Registered 4/17/2020. (Retrospectively registered).
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Background
Over 40 million epidural injections are administered every
year in the United States as per data obtained from Cen-
ters for Medicare & Medicaid Services [1]. Although gen-
erally considered a safe procedure, epidural steroid
injections are not exempt from serious complications.
There are three approaches to performing epidural injec-
tions – interlaminar approach, transforaminal approach
and caudal approach. Transforaminal epidural steroid in-
jections (TFESI) offer the advantage of placing steroids
into ventral epidural space directly over the painful spinal
nerve in patients with low back pain and/or leg pain.
Hence many practitioners prefer this technique over inter-
laminar or caudal approach, although there is no definitive
evidence to suggest one is superior to the other. Serious
but rare complications have been reported with TFESI in-
cluding spinal cord infarction, epidural hematoma, paraly-
sis, and even death. Proposed mechanisms of action
behind these devastating outcomes are arterial dissec-
tions/vasospasms, inadvertent intravascular injections or
embolization of particulate corticosteroids [2–5].
Inadvertent intravascular injection has been suggested
as the most probable mechanism behind serious neuro-
logical complications during TFESI [4–6]. The incidence
of inadvertent intravascular injection during TFESI has
been estimated to be 6–26% depending on the level of
the injection [7–12]. A review of current literature re-
veals several studies evaluating factors involved in intra-
vascular uptake during TFESI such as needle type, level of
injection, injection approach, underlying comorbidities
and so on. Among all these factors, needle type has been
studied the most. Different bevel types do not appear to
be a substantial factor in intravascular uptake during
TFESI [13–17]. Although not conclusive, blunt type nee-
dles have shown a trend towards decreased intravascular
uptake in few studies [14, 16]. In regards to level of injec-
tion, increased vascularity has been reported at the sacral
foramen and at other spinal foramen (especially cervical,
thoracic and higher lumbar levels) which can lead to in-
creased intravascular uptake [11, 18, 19]. The artery of
Adamkewicz, a major radicular artery often implicated in
spinal cord infarction during TFESI, has been reported in
anatomical studies to be found not only at higher lumbar
levels but also at lower lumbar levels [20–22]. Several
lumbosacral transforaminal epidural approaches targeting
different parts of neuroforamen have been studied and no
single approach has shown to be superior to the others in
reducing intravascular uptake [17, 23, 24].
Although several needle types have been studied in the
past, needle gauge has never been assessed with respect to
intravascular uptake. It can be beneficial to know whether
needle size plays a factor in intravascular uptake during
TFESI. This study aims to look at two needle sizes – 22-
gauge and 25-gauge needle. It can be hypothesized that
25-gauge needle due to its smaller diameter can poten-
tially lead to less intravascular uptake. Theoretically, when
taken into account the surface area covered by a needle
while it traverses through tissue planes, there is less
chance for a smaller diameter needle to encounter/punc-
ture a blood vessel during an injection compared to a lar-
ger diameter needle. Studies have also shown smaller
diameter needle to cause less pain [25]. Authors
hypothesize that the smaller 25-gauge needle can be less
painful for patients, hence making the procedure more
tolerable. On the other hand, most practitioners tend to
prefer 22-gauge needle for TFESI as it is easier to steer
through tissue planes.
There are multiple ways to assess intravascular uptake
during TFESI. Traditionally, blood aspiration, local
anesthetic test dose and/or live fluoroscopy have been
used to detect intravascular uptake during spinal proce-
dures, but none of these methods have shown to be par-
ticularly sensitive. Digital subtraction angiography (DSA)
has gained traction over the last decade and it has shown
to be much more sensitive than other methods in detect-
ing intravascular uptake [7, 26–28]. Although very sensi-
tive, DSA has not been routinely used on lumbosacral
TFESI due to the cost and increased radiation exposure to
providers (and to patients) associated with its use.
Methods
Institutional Review Board approval was obtained prior to
the initiation of this study. There was no funding source
involved in this study. Data is presented in accordance
with the Consolidated Standards of Reporting Trials
(CONSORT) statement and is available as Supplement.
All patients provided written informed consent before
participation in the study. Consecutive patients at two aca-
demic institutions from February 2018 to June 2019 were
enrolled in the study. Injections were performed by five
fellowship-trained interventional pain physicians. All in-
jections were administered with Quincke needles (sharp
bevel) and performed in outpatient fluoroscopy suites. Au-
thors chose sharp bevel needle as it is the most commonly
used needle in transforaminal epidural injections. 25-
gauge blunt or short bevel needle is hard to steer through
tissue planes lending itself limited clinical utility in trans-
foraminal epidural injections.
Inclusion criteria included 1) patients with low back
pain and/or radicular pain, 2) patients scheduled for
lumbosacral TFESI. Exclusion criteria included 1) pa-
tients with contrast/local anesthetic allergy, 2) patients
with pregnancy, coagulopathy, systemic infection, and
inability to provide informed consent, 3) vulnerable pa-
tient population including prisoners, 4) patients with se-
vere anxiety, 5) patients with prior lumbar surgery, 6)
age < 18 years old, and 7) Body Mass Index (BMI) > 40.
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One hundred sixty-two consecutive patients were re-
cruited and randomized to each arm of the study – 22-
gauge vs 25-gauge (randomization was done separately
for each provider based on a computer generated algo-
rithm). Eighty-four patients were randomized to 22-
gauge arm and 78 patients to 25-gauge arm (Fig. 1). Ini-
tial goal was to recruit around 250 patients, but due to
logistical reasons and difficulty in recruitment, study was
terminated early after enrolling 162 patients.
All injections were administered by Physical Medicine
and Rehabilitation (physiatry) specialists who had completed
a fellowship in interventional spine procedures and had at
least 1 year of experience in interventional spine care. All
practitioners used a similar approach for lumbosacral TFESI
– subpedicular/supraneural approach. The target for L1-L5
TFESI was at the superior and posterior aspect (six o’clock
position of the pedicle in the AP projection) of the lumbar
neuroforamen. The target for S1 TFESI was at the supero-
lateral aspect of dorsal S1 foramen. Providers were allowed
to switch the TFESI approach to infraneural ‘Kambin’s’ tri-
angle or interlaminar/caudal approach if the planned injec-
tion could not be administered with the initial approach.
The primary outcome measure was intravascular up-
take during live fluoroscopy and/or blood aspiration.
DSA was not available at all study locations and was
therefore not utilized. The secondary outcome measure
was patient reported pain during the procedure from 1
to 10 on the numerical rating scale (NRS).
After obtaining informed consent, patients were asked
to record pre-procedure pain level on the NRS. Study
coordinator explained the study design to the patients
and specifically asked patients to pay attention to pain
scores during 2 occasions – first one, during the initial
needle entry after they feel the burn of the numbing
agent and the second, during the administration of the
steroids towards the end of the procedure. Intervention-
alists would also remind the patients to assess their pain
during these 2 phases of the procedure. Patients were
then brought to the fluoroscopy suite and placed in
prone position on the fluoroscopy table. A procedural
time-out was then conducted as per facility guidelines.
The patients were prepped and draped in a standard
sterile fashion in the prone position and the C-arm was
positioned so that an oblique view of the neuroforamen
was visualized and target marked. The soft tissues over-
lying this structure were infiltrated with 1–5 mL of 1%
lidocaine (10 mg/mL) without epinephrine using a 27-
gauge 1.5 in. needle. Lidocaine was injected at the skin
(without creating a significant skin wheel) and through
the subcutaneous tissue to 1 to 1.5 in. depth (maximum
of 2 passes through the subcutaneous tissue). Then, a
22-gauge or 25-gauge (as per randomization) Quincke
needle was inserted toward the target using an ipsilateral
oblique trajectory view. Patients were blinded to the
gauge of the needle. The needle was advanced under an
oblique, AP and lateral visualization, to confirm correct
needle tip placement. Aspiration was confirmed to be
negative for cerebrospinal fluid and/or blood. Then a 1–
2 mL volume of contrast dye (Omnipaque-240/Iohexol
240 mg/mL) was injected under live fluoroscopy to look
Fig. 1 Study design
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for intravascular uptake. Needle tip was repositioned until
an epidural only contrast pattern was observed prior to
injecting the steroid. After obtaining satisfactory contrast
flow pattern and negative blood aspiration, the injectate (3
mL of injectate per level - mixture of 1–2mL of dexa-
methasone 10mg/mL, 1-2mL of 1% lidocaine and/or 1-2
mL of normal saline) was administered at each level along
the nerve root and into the epidural space very slowly based
on patient tolerance. Patients were reminded by interven-
tionalists to assess their pain during this time. For the pur-
poses of this study, only the initial contrast pattern was
utilized. If an epidural only contrast flow was not obtained
or persistent intravascular uptake was noted despite mul-
tiple needle redirections, the procedure was either aban-
doned or another approach was utilized (infraneural vs
caudal vs interlaminar approach) as per patient and pro-
vider discretion. Live fluoroscopy and blood aspiration were
utilized to confirm intravascular uptake at every injection
level. Intravascular injection noted by either method was re-
ported as ‘present’ for each level. Digital subtraction angiog-
raphy or lidocaine test dose method was not used to
confirm intravascular spread. At the conclusion of the pro-
cedure, all needle(s) were re-styletted, withdrawn and sterile
dressings were placed. Patients were then brought to the re-
covery area and study coordinator or nurse (who had no
knowledge of needle allocation) presented patients with
written post-procedural questionnaire (paper form). Pa-
tients were specifically asked to rate the pain during the ini-
tial needle entry and also during the administration of
injectate (steroid mixture). Overall tolerability of the pro-
cedure was also measured on an ordinal scale (‘well toler-
ated’ at 1 and ‘poorly tolerated’ at 4).
Statistical analysis
Each needle entry at any given lumbosacral level was
considered a separate incidence. For instance, a bilateral
L5 TFESI was considered 2 separate incidences. Fisher
exact test was used to detect differences between 2
groups in regards to intravascular uptake and paired t-
tests were used to detect differences in pain scores. Both
primary and secondary outcome measures were analyzed
based on intent-to-treat principle.
Results
A total of 249 TFESI injections were completed on 162
subjects. No serious complications were reported in any
patients. Baseline demographics for both study groups
are listed in Table 1.
Eighty-seven patients received 2 level injections and
the remaining 75 patients received 1 level injections.
Each level was considered a separate incidence, hence
total number of incidence was 249. Patients enrolled had
TFESI at L2 to S1 levels. The most common level of in-
jection was L5 neuroforamen for both groups. In four
patients, the target could not be obtained (all in 25-
gauge arm) due to technical difficulties (osteophytes/dif-
ficult anatomy) hence reassigned to 22-gauge needle arm
and was completed successfully. Two other patients in
22-gauge group (both at S1 neuroforamen) were reas-
signed to interlaminar or caudal approach due to persist-
ent intravascular uptake. All other patients had
successful completion of the injection according to their
assignments.
The overall incidence of intravascular uptake for both
the 22-gauge and 25-gauge group was 6.4% (16 out of
249) in this study. The incidence of intravascular uptake
for 22-gauge group was 5.9% (8 out of 136, 95% confi-
dence interval: 1.9 to 9.8%). The incidence of intravascu-
lar uptake for 25-gauge group was 7.1% (8 out of 113,
95% confidence interval: 2.4 to 11.8%). There was no sta-
tistically significant difference between both groups in
regards to intravascular uptake (p = 0.701, Fig. 2).
Further analysis of intravascular uptake between differ-
ent levels yielded no statistically significant differences
(Table 2). There was a trend towards increased intravas-
cular uptake incidence at S1 level among both groups,
but was not statistically significant (p value = 0.767,
Table 2).
Pain scores (NRS) for 22-gauge and 25-gauge groups
are listed in Table 3. There was no statistically signifi-
cant difference in pain scores (during initial needle entry
and administration of injectate) between both groups
(Table 3). Injection tolerability was also measured (well
tolerated =1, poorly tolerated = 4) and average score for
22-gauge group and 25-gauge group was 1.24 and 1.23
respectively (p = 1.000). Again, both groups showed no
statistically significant difference in overall tolerability.
Discussion
The results of this study showed no statistically signifi-
cant difference between the use of a 22-gauge and 25-
gauge needle in regards to intravascular uptake or pain
scores. One would expect the smaller gauge needle to
reduce incidence of intravascular uptake but this study
did not demonstrate any benefit in using a smaller bore
25-gauge needle as opposed to a larger bore 22-gauge
needle. On the contrary, there seemed to be some disad-
vantage in using the 25-gauge needle as it can be hard to
Table 1 Patient baseline demographic data
22-gauge (n = 84) 25-gauge (n = 78) p-value
Age (years) 60.0 57.7 0.322
Sex (M:F) M-45%; F-55% M-52%; F-48% 0.543
Diagnosis
-Radiculopathy 73.8% 80.7%
-Spinal Stenosis 22.6% 14.1%
-Other 3.6% 5.2%
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penetrate firm ligaments/skin and navigate around osteo-
phytes, hence harder to steer and reach the target. Even
though this study excluded patients with BMI > 40, all
interventionalists found it less desirable to use 25-gauge
needle as it took longer and required more fluoroscopic
images to complete the procedure. In addition, it is to be
noted that there were 6 cases in this study which switched
assignment after randomization, and 4 of them were in
25-gauge arm (all of them due to technical challenge in
obtaining the target at L4 and/or L5 levels). The other 2
assignment changes were due to persistent intravascular
uptake, hence reassigned to interlaminar approach. Al-
though not quantified in this study, 25-gauge needle can
be difficult to steer through deeper tissue planes limiting
its potential use in clinical practice. In this study, there
was no outcome measure to gauge the difficulty level asso-
ciated with completing a lumbosacral TFESI using 25-
gauge needle. Authors recommend future studies looking
at procedure time/exposure to further quantify this
phenomenon in a more objective manner.
Although patients with lumbar surgery were excluded
from the study, low thoracic and sacral surgeries can
also result in increased vascularity in lumbar region due
to post-surgical changes. On post-hoc analysis, none of
the patients had documented low thoracic or sacral sur-
geries prior to enrolling in the study.
The study may also suggest that a smaller gauge nee-
dle may not lead to less pain. Although the study was
not well designed to detect the differences in pain per-
ception, the results suggest no difference in pain scores
or tolerability between the 2 groups. Patients were spe-
cifically asked to rate the pain during the initial needle
entry and also during the administration of injectate
(steroid mixture) hoping to differentiate pain experi-
enced at various stages of the procedure, but no statisti-
cally significant differences were observed.
Limitations
Similar to prior studies on intravascular uptake, one of
the limitations of this study was also the relatively small
sample size. A sample size of 249 was not enough to de-
tect small changes that may exist between the 2 groups
especially given the low overall incidence of intravascular
uptake during TFESI. Also true randomization at injec-
tion event level was not possible as one patient could
have had multiple events. Although initial goal was to
recruit around 250 patients, study was terminated early
at 162 patients, hence an ‘event’ was changed from pa-
tients to level of injections for statistical analysis possibly
implying cluster randomization.
Authors did not use digital subtraction angiography to
detect intravascular uptake as it was not available at all
study locations. Instead, standard live fluoroscopy and/
or vascular aspiration were used. Studies have shown
DSA to increase the sensitivity of detecting intravascular
uptake [7, 26–28].
Pain scores were obtained after the procedure when
patients were in the recovery room which could have led
to recall bias. When patients were asked to rate pain
during the initial needle entry, they could in fact be
assessing the needle used for local anesthetic infiltration.
More accurate pain scores could have been obtained if
asked during the procedure immediately after placement
Fig. 2 The incidence of intravascular uptake for 22-gauge group was 5.9% (8 out of 136) and 25-gauge group was 7.1% (8 out of 113) (p = 0.701)
Table 2 Intravascular uptake incidence per level
Levels 22-gauge (n = 136) 25-gauge (n = 113) p-value
L2 1/4 0/7
L3 0/17 3/19
L4 0/33 0/32
L5 2/66 0/32
S1 5/16 5/23 0.767
Overall incidence 8/136 (5.9%) 8/113 (7.1%) 0.701
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of the needle and administration of steroids. Although
the procedure was standardized in the research protocol,
there may still be differences in how the injection was
performed between various interventionalists (five in this
study) which can affect patients’ pain perception. Sensi-
tivity analysis (taking into consideration individual pro-
vider variability) appeared to affect pain scores but had
limited impact on the rate of intravascular uptake.
Conclusions
One would expect the smaller 25-gauge needle to reduce
incidence of intravascular uptake and be less painful
during TFESI, but the study finds no conclusive evi-
dence. In conclusion, the study showed no statistically
significant difference in intravascular uptake or pain per-
ception between a 22-gauge needle and 25-gauge needle
during lumbosacral TFESI.
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